US Broker Ratings

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: A Biotech Prospect with Nearly 92% Upside Potential

Trevi Therapeutics, Inc. (NASDAQ: TRVI) stands out in the biotechnology sector with a promising outlook for investors seeking growth opportunities in the healthcare industry. With a market capitalization of $1.44..

Anavex Life Sciences Corp. (AVXL) Stock Analysis: Exploring a Potential 373% Upside in the Biotech Sector

Anavex Life Sciences Corp. (NASDAQ: AVXL), a prominent player in the biotechnology sector, has been capturing investor attention with its ambitious pipeline geared towards tackling neurodegenerative diseases. With a current..

GH Research PLC (GHRS) Stock Analysis: Potential Upside of 152.90% Amid Strong Buy Ratings

Ireland-based GH Research PLC (NASDAQ: GHRS) is a promising player in the biotechnology industry, specializing in the development of innovative treatments for depression. With a market capitalization nearing the $1..

Cronos Group Inc. (CRON) Stock Analysis: Navigating the Cannabis Market with 47% Revenue Growth

Cronos Group Inc. (NASDAQ: CRON) stands as a notable player in the burgeoning cannabis industry, with its headquarters rooted in Stayner, Canada. As a company engaged in the cultivation, production,..

InMode Ltd. (INMD) Stock Analysis: 31.66% Potential Upside in the Healthcare Sector

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, particularly within the medical devices industry, presents an intriguing investment opportunity for those with an eye on the future..

RxSight, Inc. (RXST) Stock Analysis: Unveiling the 31.62% Potential Upside for Investors

RxSight, Inc. (NASDAQ: RXST), a commercial-stage medical technology firm, is garnering attention in the healthcare sector for its innovative approach to cataract surgery. The company specializes in light adjustable intraocular..

CorMedix Inc. (CRMD) Stock Analysis: A 127.68% Potential Upside with DefenCath at the Forefront

CorMedix Inc. (CRMD), a promising player in the biotechnology sector, is drawing significant attention from investors seeking robust growth opportunities. With its market capitalization standing at $505.92 million, the company..

Evolus, Inc. (EOLS) Stock Analysis: Exploring a Potential 198% Upside in the Aesthetic Market

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company headquartered in Newport Beach, California, operates in the dynamic healthcare sector, specifically within the drug manufacturers specializing in specialty and generic products...

Sionna Therapeutics, Inc. (SION) Stock Analysis: A Biotech Contender with a 33.89% Potential Upside

Sionna Therapeutics, Inc. (NASDAQ: SION) has emerged as a compelling player in the healthcare sector, specifically within the biotechnology industry. With a current market capitalization of $1.65 billion, this clinical-stage..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Assessing 23.75% Potential Upside in a Dynamic Biotech Sector

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) is a noteworthy player in the biotechnology industry, a sector that continues to captivate investors with its potential for groundbreaking innovations and substantial returns...

Nuvation Bio Inc. (NUVB) Investor Outlook: 164% Potential Upside and Robust Revenue Growth

Nuvation Bio Inc. (NASDAQ: NUVB) stands out in the biotechnology sector with a remarkable potential upside of 164.43%, making it an intriguing prospect for investors looking for high-growth opportunities. The..

Vir Biotechnology, Inc. (VIR) Investor Outlook: Analyzing a 119% Potential Upside

Vir Biotechnology, Inc. (NASDAQ: VIR), a clinical-stage biopharmaceutical company, is garnering significant attention from investors due to a remarkable potential upside of 119.17%. With its focus on combating serious infectious..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Exploring a Potential 52% Upside as Analysts Show Strong Support

Cogent Biosciences, Inc. (NASDAQ: COGT) is making waves in the biotech sector with its promising portfolio of precision therapies targeting genetically defined diseases. Based in Waltham, Massachusetts, Cogent Biosciences is..

Ardelyx, Inc. (ARDX) Stock Analysis: Potential Upside of 184% with Strong Buy Ratings

Ardelyx, Inc. (NASDAQ: ARDX) has recently captured the attention of investors in the biotechnology sector, boasting a compelling narrative underpinned by a promising product pipeline and significant projected upside. The..

Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: 63% Potential Upside Amid Robust Revenue Growth

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a key player in the biotechnology sector, is poised for significant investor attention as it navigates the competitive landscape of cancer therapy development. With a..

Investor Outlook: AMN Healthcare Services Inc (AMN) Targets a 14.62% Upside Amid Sector Growth

AMN Healthcare Services Inc (AMN), a prominent player in the Medical Care Facilities industry, is capturing investor interest with its robust service offerings and a promising potential upside of 14.62%...

Embecta Corp. (EMBC) Stock Analysis: Exploring an 89% Potential Upside

Embecta Corp. (NYSE: EMBC), a key player in the medical instruments and supplies industry, is currently catching investor attention with its significant potential upside of 89.18%. This healthcare-focused company, headquartered..

Immunome, Inc. (IMNM) Stock Report: Exploring a 69% Upside in Biotech Innovation

Immunome, Inc. (NASDAQ: IMNM), a prominent player in the biotechnology sector, is capturing significant investor attention with a remarkable potential upside of 69.31%. With a current market capitalization of $2.32..

Rocket Pharmaceuticals, Inc. (RCKT) Investor Outlook: Exploring a 66.76% Potential Upside

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) stands at the forefront of the biotechnology industry, emphasizing the development of genetic therapies for rare and devastating diseases. Despite its current challenges, the company..

CeriBell, Inc. (CBLL) Stock Analysis: A Promising 51.73% Upside in the Medical Devices Sector

Investors eyeing opportunities in the healthcare sector may want to turn their attention to CeriBell, Inc. (CBLL), a company that stands out for its innovative approach to medical technology. With..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds